Page last updated: 2024-12-06

trioctylmethylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trioctylmethylammonium (TOMA) is a quaternary ammonium compound commonly used as a phase-transfer catalyst. It is a colorless liquid that is soluble in organic solvents and insoluble in water. It is synthesized through the reaction of tri-n-octylamine with methyl chloride. TOMA acts as a catalyst by transferring ions from an aqueous phase to an organic phase, facilitating reactions that would otherwise be slow or impossible. It has applications in various fields, including organic synthesis, polymer chemistry, and environmental remediation. For example, it is used in the production of pesticides and pharmaceuticals. TOMA has also been studied for its potential applications in separating and purifying metals. It is important to note that TOMA is a toxic compound and should be handled with care. Its toxicity is related to its ability to disrupt cell membranes and can cause irritation and other adverse effects. Therefore, it is essential to use appropriate safety measures when working with this compound.'

trioctylmethylammonium: used in high performance liquid chromatography for the separation of tRNA; RN given refers to chloride [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

methyltrioctylammonium : A quaternary ammonium ion with three octyl groups and one methyl group attached to the nitrogen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID21219
CHEMBL ID1197179
CHEBI ID75293
SCHEMBL ID80010
MeSH IDM0114025

Synonyms (25)

Synonym
trioctylmethylammonium
nsc-221149
nsc221149
methyl(trioctyl)azanium
CHEMBL1197179
tricaprylmethylammonium
methyltricaprylylammonium
methyltrioctylammonium
n-methyl-n,n-dioctyl-1-octanaminium
CHEBI:75293 ,
22061-11-6
1-octanaminium, n-methyl-n,n-dioctyl-
SCHEMBL80010
n-methyl-n,n-dioctyloctan-1-aminium
DTXSID7045027
AKOS024269110
methyltricaprylylammonium ion
OSG1QL6NZ0 ,
tricaprylylmethylammonium
methyltricaprylylammonium cation
trioctylmethylammonium cation
tricaprylyl(monomethyl)ammonium
ammonium, methyltrioctyl-
unii-osg1ql6nz0
Q27145197

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The optimum adsorbent dosage was 2 g/L with high adsorption behaviour in a wide pH range of 7-11."( Novel Aliquat-336 impregnated chitosan beads for the adsorptive removal of anionic azo dyes.
Ayati, A; Ranjbari, S; Sillanpää, M; Tanhaei, B, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quaternary ammonium ionA derivative of ammonium, NH4(+), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (67)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (7.46)18.7374
1990's4 (5.97)18.2507
2000's22 (32.84)29.6817
2010's26 (38.81)24.3611
2020's10 (14.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.76 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index42.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other71 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]